Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine

por Ünsal C, Albayrak Y, Albayrak N, Kuloğlu M, Hashimoto K
Publicado 2013

Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia

por Ünsal C, Oran M, Tureli HO, Alpsoy S, Yeşilyurt S, Arslan M, Topcu B, Karakaya O, Kurt E
Publicado 2013

Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study

por Beyazyüz M, Küfeciler T, Bulut L, Ünsal C, Albayrak Y, Akyol ES, Baykal S, Kuloglu M, Hashimoto K
Publicado 2016